Related Experiment Videos
Valdecoxib for the management of chronic and acute pain
1Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9068, USA. girish.joshi@utsouthwestern.edu
Abstract:
Cyclooxygenase-2 specific inhibitors have anti-inflammatory and analgesic properties, and are effective in managing a wide range of chronic and acute painful conditions such as adult rheumatoid arthritis, osteoarthritis, migraine, primary dysmenorrhea and postoperative pain. Valdecoxib, an orally administered cyclooxygenase-2 specific inhibitor, provides effective pain relief for both chronic and acute conditions, and reduces postoperative opioid use, with a concomitant reduction in opioid-related adverse events. Valdecoxib also has superior gastrointestinal safety compared with nonspecific nonsteroidal anti-inflammatory drugs, and at therapeutic doses, it is generally safe and well tolerated in terms of renal and cardiovascular events. This drug profile reviews the efficacy, safety and tolerability of valdecoxib for the management of chronic and acute pain.
Related Concept Videos
Analgesia and Pain Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Angina IV: Management
Drugs for Treatment of Ulcerative Colitis in IBD
Rheumatic Heart Disease III: Medical Management
COPD: Management Using Bronchodilators and Corticosteroids